Table 1.
Basic information and clinical characteristics of 25 COVID-19 patients
| Information | Number (%) |
|---|---|
| Characteristic | |
| Sex | |
| Male | 15 (60%) |
| Female | 10 (40%) |
| Age (year) | |
| 24–88 | 52 ± 19.30 |
| Exposure | |
| Wuhan contact | 13 (52%) |
| Family cluster/confirmed patient contact | 10 (40%) |
| Unknown | 2 (8%) |
| Comorbidity | |
| Total | 12 (48%) |
| Diabetes | 5 (20%) |
| Hypertension | 5 (20%) |
| Cardiac disease | 2 (8%) |
| Hepatic adipose infiltration | 1 (4%) |
| Coronary disease | 1 (4%) |
| Chronic obstructive pulmonary disease | 1 (4%) |
| Syphilis | 1 (4%) |
| Latent period | |
| 4–21 days | 8.90 ± 4.95 days |
| Diagnosis time | |
| 0–13 days | 6.64 ± 3.82 days |
| From initial symptoms | |
| Initial symptoms | |
| Fever (38.1 ± 0.72 °C) | 23 (92%) |
| Cough | 15 (60%) |
| Fatigue | 14 (56%) |
| Phlegm | 9 (36%) |
| Dyspnea | 7 (28%) |
| Sore throat | 5 (20%) |
| Loss of appetite | 3 (12%) |
| Stuffy and runny nose | 2 (8%) |
| Diarrhea | 2 (8%) |
| Nausea and vomiting | 1 (4%) |
| Laboratory examination | |
| WBC, normal or reduced | 24 (96%) |
| Lymphocyte reduced | 15 (60%) |
| CRP elevated | 12 (48%) |
| ESR elevated | 11 (44%) |
| AST elevated | 4 (12.67%) |
| CK elevated | 1 (4%) |
| CK-MB elevated | 2 (8%) |
CRP C-reactive protein, ESR erythrocyte sedimentation rate, AST aspartate aminotransferase, CK creatine kinase